PRLeap - Biotech News Releases

Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect

Mon, 23 Feb 2026 21:05:00 PST

Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect

Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site

Tue, 29 Apr 2025 05:00:00 PDT

The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing, testing and release of recombinant Cas9 nuclease.

CO.DON GmbH partners in EU-Funded Project to Advance 3D Bioprinting for Tissue Regeneration

Wed, 05 Feb 2025 06:00:00 PST

Teltow, 05. February 2025 The EU-funded micro2MACRO (m2M) project, launched in December 2024, aims to advance tissue regeneration through an innovative bioprinting platform.

LTS wins funding from BARDA's Patch Forward Prize Competition for two partnerships

Tue, 14 Jan 2025 03:15:00 PST

Andernach LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies.

Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy

Fri, 26 Jan 2024 05:20:00 PST

Biomay, a biotech contract development and manufacturing organization based in Vienna, Austria, announces successful completion of an FDA inspection qualifying Biomay as a cGMP manufacturer and supplier of recombinant nuclease Cas9 for use in gene editing therapies.

Farmington Hills, MI Author Publishes Book on Co-Parenting

Fri, 01 Sep 2023 04:00:00 PDT

A Guide to Managing Post-Divorce, Child-Related Conflict.

Björn Cochlovius New CEO of Eleva

Wed, 03 May 2023 07:30:00 PDT

Björn Cochlovius Ph.D. has become the new CEO of Eleva, a Freiburg-based biotech company and the developer of "Bryotechnology", a unique and pioneering process for the moss-based production of complex therapeutic proteins.

Stem cell therapy for "Butterfly disease" / RHEACELL receives 'Partners in Progress Award' from debra of America for Epidermolysis Bullosa research

Wed, 09 Nov 2022 01:50:00 PST

Heidelberg, November 9, 2022. The biopharmaceutical company RHEACELL, which specializes in stem cells, was honored on October 24 by the organization 'Dystrophic Epidermolysis Bullosa Research Association of America' (debra) with the 'Partners in Progress Award'.

Bryan, TX Author Publishes Science Fiction Novel

Fri, 14 Oct 2022 00:39:00 PDT

In The Future, Sentient Artificial Intelligence Beings Want Their Own World - Away from Humans!

Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million

Thu, 04 Aug 2022 00:01:00 PDT

Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal's investigational medicine Resiniferatoxin ("RTX").

Pasco, WA Author Publishes Novel

Sat, 16 Jul 2022 04:00:00 PDT

In This Fantasy Novel a Young Hero Must Find a City Hidden in the Clouds - A City that Holds a Cure for His Sister's Illness.

Leukocare announces new management structure to support global set-up and accelerate growth

Thu, 30 Jun 2022 05:00:00 PDT

Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced the introduction of a new management structure, effective July 1st, 2022

Dr. Dirk Winnemöller joins Leukocare as Vice President Commercial

Wed, 03 Nov 2021 02:15:00 PDT

Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced that Dr. Dirk Winnemöller took up the newly established role as Vice President Commercial at Leukocare.

Arcade, NY Author Publishes Children's Book

Mon, 23 Aug 2021 03:00:00 PDT

In This Kids Book a Cat Goes on an Adventure to Find a New Home Based on a True Story!

Biomay Cooperates with BioNTech to Supply DNA Template for COVID-19 mRNA Vaccine

Tue, 18 May 2021 01:00:00 PDT

Biomay, a Vienna based biotech manufacturer, today announced their partnership with BioNTech SE to support the supply chain for manufacturing of the Pfizer-BioNTech COVID-19 mRNA vaccine.

ESC Takes Part in Georgian College's RISE 2021 Research & Innovation Event

Tue, 06 Apr 2021 00:00:00 PDT

ESC Takes Part in Georgian College's RISE 2021 Research & Innovation Event

Aaron Styles, VP of Environmental Systems Corporation, Named Board President of ISPE Canada

Tue, 23 Mar 2021 00:30:00 PDT

Aaron Styles, VP of Environmental Systems Corporation, Named Board President of ISPE Canada.

ISPE Canada Affiliate Names New 2021 Executive Board and Board of Directors

Tue, 16 Mar 2021 00:00:00 PDT

ISPE Canada Affiliate Names New 2021 Board Members.

Regulatory breakthrough for BrainRepair UG start-up Stem cell treatment for newborns / EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan

Wed, 30 Sep 2020 06:00:00 PDT

Bochum's medics have developed a unique method based on own (autologous) cord blood stem cells to treat white matter brain damage causing cerebral palsy (CP) in newborn babies for which the European Medicines Agency has granted the worldwide first 'Orphan Drug Designation' (ODD).

Jennewein Biotechnologie GmbH announces the foundation of Jennewein Biotech Corp. USA

Thu, 30 Jul 2020 01:00:00 PDT

Jennewein Biotechnologie GmbH, a market leading and science-based company for developing and producing human milk oligosaccharides (HMOs) and rare monosaccharides, announced today that it has established its subsidiary in the USA. Jennewein Biotech USA Corporation, a Delaware Corporation, utilizing warehouses in Chicago, IL and Columbus, OH, will help to better serve our US and North American customers.

Swiss EPFL spin-off EMBION Technologies S.A. revolutionizes biomass upcycling

Wed, 08 Jul 2020 00:00:00 PDT

New patented solution PREMBION(TM) paves the way to antibiotic-free farming. EMBION's rapid-prototyping platform technology pioneers the affordable future of nutrition.

BioGX, Bosch Healthcare Solutions partner to expand molecular diagnostic tests offering for the Vivalytic platform / New biocontent cooperation with renowned US firm

Tue, 19 May 2020 00:20:00 PDT

- Bosch Healthcare Solutions and BioGX announce partnership for point of care molecular tests - Partnership will accelerate planned expansion of the test portfolio for the Vivalytic all-in-one platform.

Nolensville, TN Author Publishes Children's Book

Tue, 28 Apr 2020 04:35:00 PDT

In This Kids Book a Little Girl Goes on Big Adventures!

Elastrin Therapeutics develops new approach against "Inflammatory Storm" that kills most Corona patients

Thu, 26 Mar 2020 10:30:00 PDT

A previously untested approach to preventing the most severe outcomes of lung diseases, including COVID-19, has been developed by Elastrin Therapeutics based on targeting damaged elastic fiber that leads to impaired lung function. The company has developed the world's first humanized antibody that specifically targets exposed elastin fiber, and is pursuing investment to further develop a therapy.

Jennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany

Fri, 10 Jan 2020 05:05:00 PST

Jennewein Biotechnologie GmbH filed a patent infringement suit with the regional court in Mannheim on January 09, 2020 against Nestlé Nutrition GmbH and its holding company Nestlé Deutschland AG.

Former Professor Publishes Book on American Economic Class System

Fri, 06 Dec 2019 03:30:00 PST

This Book is a Detailed Look at the Economic Class System in Modern America.

Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2'-fucosyllactose fermentation strain.

Mon, 25 Nov 2019 01:15:00 PST

The FDA has acknowledged that Jennewein's 2'-fucosyllactose is Generally Recognized As Safe (GRAS)

Jennewein Biotechnologie sues Glycom for patent infringement in Denmark

Mon, 25 Nov 2019 01:00:00 PST

Jennewein is suing Denmark's Glycom A/S for infringing on its European Patent Patent EP 2 896 628 B1, used in the biotechnological production of HMOs

Crystal E A More Effective Vitamin E Form

Tue, 01 Oct 2019 00:00:00 PDT

Harnessing the use of crystallization with Crystal E

Administrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity

Wed, 11 Sep 2019 08:00:00 PDT

September 11, 2019 - On September 09, 2019, Administrative Law Judge Cameron Elliot of the US International Trade Commission issued an Initial Determination finding that one of the bacterial strains used by Jennewein Biotechnologie to make 2'-fucosyllactose (2'-FL) infringes a patent owned by Glycosyn LLC.

PRLeap - Biotech News Releases

Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect

Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site

CO.DON GmbH partners in EU-Funded Project to Advance 3D Bioprinting for Tissue Regeneration

LTS wins funding from BARDA's Patch Forward Prize Competition for two partnerships

Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy

Farmington Hills, MI Author Publishes Book on Co-Parenting

Björn Cochlovius New CEO of Eleva

Stem cell therapy for "Butterfly disease" / RHEACELL receives 'Partners in Progress Award' from debra of America for Epidermolysis Bullosa research

Bryan, TX Author Publishes Science Fiction Novel

Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million

Pasco, WA Author Publishes Novel

Leukocare announces new management structure to support global set-up and accelerate growth

Dr. Dirk Winnemöller joins Leukocare as Vice President Commercial

Arcade, NY Author Publishes Children's Book

Biomay Cooperates with BioNTech to Supply DNA Template for COVID-19 mRNA Vaccine

ESC Takes Part in Georgian College's RISE 2021 Research & Innovation Event

Aaron Styles, VP of Environmental Systems Corporation, Named Board President of ISPE Canada

ISPE Canada Affiliate Names New 2021 Executive Board and Board of Directors

Regulatory breakthrough for BrainRepair UG start-up  Stem cell treatment for newborns / EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan

Jennewein Biotechnologie GmbH announces the foundation of Jennewein Biotech Corp. USA

Swiss EPFL spin-off EMBION Technologies S.A. revolutionizes biomass upcycling

BioGX, Bosch Healthcare Solutions partner to expand molecular diagnostic tests offering for the Vivalytic platform / New biocontent cooperation with renowned US firm

Nolensville, TN Author Publishes Children's Book

Elastrin Therapeutics develops new approach against "Inflammatory Storm" that kills most Corona patients

Jennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany

Former Professor Publishes Book on American Economic Class System

Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2'-fucosyllactose fermentation strain.

Jennewein Biotechnologie sues Glycom for patent infringement in Denmark

Crystal E A More Effective Vitamin E Form

Administrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity

Regulatory breakthrough for BrainRepair UG start-up Stem cell treatment for newborns / EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan

Swiss EPFL spin-off EMBION Technologies S.A. revolutionizes biomass upcycling

Crystal E A More Effective Vitamin E Form